The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.63

Today's change-0.66 -4.97%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

Allscripts Healthcare Solutions Inc

Nasdaq: MDRX
Last

(U.S.) $12.63

Today's change-0.66 -4.97%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Allscripts Healthcare Solutions Inc down (U.S.)$0.66

Allscripts Healthcare Solutions Inc closed sharply lower Friday, dropping (U.S.)$0.66 or 4.97% to (U.S.)$12.63. Over the last five days, shares have lost 8.35% and are down 17.88% for the last year to date. This security has outperformed the S&P 500 by 13.49% during the last year.

Key company metrics

  • Open(U.S.) $13.22
  • Previous close(U.S.) $13.29
  • High(U.S.) $13.22
  • Low(U.S.) $12.55
  • Bid / Ask-- / --
  • YTD % change-17.88%
  • Volume1,916,975
  • Average volume (10-day)2,639,807
  • Average volume (1-month)2,786,107
  • Average volume (3-month)2,709,511
  • 52-week range(U.S.) $11.33 to (U.S.) $15.78
  • Beta1.03
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward27.26×
  • Forward PEG0.88×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.11
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-1.49%

Although this company's net profit margin is negative, it is above the industry average and implies that Allscripts Healthcare Solutions Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue354352335341
Total other revenue--------
Total revenue354352335341
Gross profit153144130136
Total cost of revenue201208205205
Total operating expense346346340340
Selling / general / administrative91878285
Research & development48444742
Depreciation / amortization6779
Interest expense (income), net operating--------
Unusual expense (income)0000
Other operating expenses, total--------
Operating income96-61
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-1-2-11-7
Income after tax-5-3-10-2
Income tax, total41-1-4
Net income-5-3-10-2
Total adjustments to net income--------
Net income before extra. items-5-3-10-2
Minority interest00----
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-5-3-10-2
Inc. avail. to common incl. extra. items-5-3-10-2
Diluted net income-5-3-10-2
Dilution adjustment--------
Diluted weighted average shares189182181180
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.02-0.06-0.01
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.03-0.02-0.06-0.01